Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Glycoprobe AB
AB
Active
Org 5567295216
Scheelevägen 27, 223 63
Lund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2007 · 19 years old
6 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Glycoprobe AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
14M
10M
7M
3M
0M
2020: 8M
8M
2020
2021: 8M (0% vs 2020)
8M
0%
2021
2022: 10M (+25% vs 2021)
10M
+25%
2022
2023: 11M (+10% vs 2022)
11M
+10%
2023
2024: 10M (-9% vs 2023)
10M
-9%
2024
EBITDA
SEK millions
2M
2M
1M
1M
0M
2020: 1M
1M
2020
2021: 0M (-100% vs 2020)
0M
-100%
2021
2022: 2M
2M
2022
2023: 1M (-50% vs 2022)
1M
-50%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
9 867
11 378
9 618
7 882
7 876
Staff expenses
—
—
—
—
—
EBITDA
1 299
1 322
1 798
102
723
Depreciation & amort.
−1 277
−8 131
−1 495
−1 449
−1 172
EBIT
22
−6 809
303
−1 347
−449
Net financials
−22
−40
−30
−8
—
Profit before tax
296
−6 849
0
0
−403
Tax
−0
−0
−0
−0
−0
Net profit
296
−6 849
0
0
−403
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
12 757
14 131
21 120
20 426
19 722
Equity
2 152
1 856
1 856
1 856
1 856
Long-term debt
0
277
555
832
0
Short-term debt
10 042
11 139
17 851
17 152
17 605
Total debt
10 042
11 416
18 406
17 984
17 605
Financial ratios
5-year trend
EBITDA margin
13,2 %
This company
15,8 %
Market median
This company
Market median
16% below market
2020
2024
Equity ratio
16,9 %
This company
38,2 %
Market median
This company
Market median
56% below market
2020
2024
Return on equity
13,8 %
This company
18,4 %
Market median
This company
Market median
25% below market
2020
2024
Net profit margin
3,0 %
This company
8,1 %
Market median
This company
Market median
63% below market
2020
2024
Asset turnover
0,77×
This company
1,12×
Market median
This company
Market median
31% below market
2020
2024
Debt / equity
4,93×
This company
0,62×
Market median
This company
Market median
695% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Glycoprobe AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
